Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis(®) (Ranibizumab) Biosimilar

por Kim, Eunji, Han, Jihyeon, Chae, Yunjung, Park, Hyerim, Kim, Saerom, Kim, Seokkyun, Lee, Jungmin, Kim, Beom Chan
Publicado 2022

Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar

por Kim, Seokkyun, Song, Jinsu, Park, Seungkyu, Ham, Sunyoung, Paek, Kyungyeol, Kang, Minjung, Chae, Yunjung, Seo, Heewon, Kim, Hyung-Chan, Flores, Michael
Publicado 2017